Christopher Daugherty to Antineoplastic Agents
This is a "connection" page, showing publications Christopher Daugherty has written about Antineoplastic Agents.
Connection Strength
0.495
-
A Qualitative Analysis of Oncology Patient Awareness of Medication Shortages and Their Preferences for How Shortages Should Be Managed. JCO Oncol Pract. 2020 10; 16(10):e1098-e1111.
Score: 0.289
-
Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. J Clin Oncol. 2007 Feb 10; 25(5):548-54.
Score: 0.115
-
Ethical issues in the development of new agents. Invest New Drugs. 1999; 17(2):145-53.
Score: 0.066
-
Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol. 1995 May; 13(5):1062-72.
Score: 0.013
-
Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials. J Natl Cancer Inst. 1994 Nov 16; 86(22):1685-93.
Score: 0.012